Vitrolife is a global company contributing products within the IVF field. Our mission is to support customers to achieve successful treatment outcomes by providing valued solutions and services for assisted reproduction.
Founded in 1994 Vitrolife was one of the first companies providing IVF laboratories with high quality ready-to-use culture media. Today our portfolio holds products all the way from oocyte retrieval to transfer of the embryo.
Vitrolife has approximately 370 employees and the headquarter is located in Sweden with additional locations and production facilities in more than ten countries world-wide.
The Vitrolife share is listed on the NASDAQ Stockholm, Nordic Mid Cap.